Investigating how lipid antigens contribute to inflammation in Type 2 Diabetes
Lipid Antigen Presentation as a Driver of T2D Inflammation
This study is looking at how certain fats in the body might cause ongoing inflammation that can make Type 2 Diabetes worse, using special mice and lab tests to learn more about how this happens.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10923566 on NIH RePORTER |
What this research studies
This research explores the role of lipid antigens in driving chronic inflammation associated with Type 2 Diabetes (T2D). By using transgenic mice that express human CD1 molecules, the study aims to uncover how these lipid antigens influence immune responses and contribute to insulin resistance. The researchers will also utilize in vitro models to further understand the mechanisms at play. This approach seeks to fill a critical gap in knowledge regarding the initiators of inflammation in T2D, which has been largely overlooked in previous studies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 2 Diabetes who may benefit from new therapeutic approaches targeting inflammation.
Not a fit: Patients without Type 2 Diabetes or those whose condition is not influenced by inflammation may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new anti-inflammatory therapies for patients with Type 2 Diabetes.
How similar studies have performed: While the role of lipid antigens in inflammation is a relatively novel area of investigation, previous studies have shown promise in understanding immune responses in other contexts.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Nicholas, Dequina Angelina — University of California-Irvine
- Study coordinator: Nicholas, Dequina Angelina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.